82 related articles for article (PubMed ID: 19365389)
1. [Efficacy of cereton in the acute period of ischemic stroke].
Ismagilov MF; Vasilevskaia OV; Gaĭfutdinov RT; Strakhova TM; Kuz'mina IA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):35-6. PubMed ID: 19365389
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and tolerability of choline alphoscerate (cereton) in patients with Parkinson's disease with cognitive disorders].
Levin OS; Batukaeva LA; Anikina MA; Iunishchenko NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):42-6. PubMed ID: 20032953
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of cereton in acute ischemic stroke: results of the trial SOLNTSE].
Kamchatnov PR; Abusueva BA; Evzel'man MA; Esin RG; Kol'iak EV; Novikova LB; Prikazchikov SV; Riabov AG; Umarova KhIa; Boĭko AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 2):10-4. PubMed ID: 22677763
[TBL] [Abstract][Full Text] [Related]
4. [The use of cereton in ischemic stroke].
Maslova NN; Pysina AM
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 23():21-2. PubMed ID: 19431273
[No Abstract] [Full Text] [Related]
5. [The use of cereton in the rehabilitation of patients with hemorrhagic stroke].
Buĭlova TV; Glotova ME; Khalak ME; Vashkevich VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5 Suppl 2):57-61. PubMed ID: 19894302
[TBL] [Abstract][Full Text] [Related]
6. [The domestic drug cereton in the treatment of patients in the acute period of ischemic stroke].
Shmyrev VI; Kryzhanovskiĭ SM
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):53-6. PubMed ID: 19253468
[No Abstract] [Full Text] [Related]
7. [The use of cerepro (choline alfoscerate) in the treatment of outpatients with chronic progressive cerebrovascular disease].
Kostenko EV; Petrova LV; Artemova IIu; Vdovichenko TV; Ganzhula PA; Ismailov AM; Lisenker LN; Petrov SV; Otcheskaia OV; Rotor LD; Khozova AA; Boĭko AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):24-30. PubMed ID: 22677751
[TBL] [Abstract][Full Text] [Related]
8. [Possibilities of cavinton therapy regimen for infusions and cavinton comforte in acute and early recovery periods after ischemic stroke].
Belova LA; Mashin VV; Proshin AN; Ovsyannicova AN; Kostishko BB
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):51-58. PubMed ID: 29053121
[TBL] [Abstract][Full Text] [Related]
9. [Results of the multicenter prospective study of cerebrolysin safety and efficacy in acute stroke].
Skwortsova VI; Stakhovskaia LV; Shamalov NA; Kerbikov OB
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():41-5. PubMed ID: 18196634
[TBL] [Abstract][Full Text] [Related]
10. [The use of cereton in patients with chronic brain ischemia and moderate cognitive impairment].
Pizova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):78-83. PubMed ID: 25726784
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of the combined therapy with citicholine and actovegin in the acute period of ischemic stroke].
Shamalov NA; Stakhovskaia LV; Shetova IM; Efremova NM; Anisimov KV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9 Pt 2):13-7. PubMed ID: 21462435
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of cytoflavin in patients in the acute ischemic stroke].
Odinak MM; Skvortsova VI; Vozniuk IA; Rumiantseva SA; Stakhovskaia LV; Klocheva EG; Novikova LB; Ianishevskiĭ SN; Golokhvastov SIu; Tsygan NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):29-36. PubMed ID: 21311484
[TBL] [Abstract][Full Text] [Related]
13. [Use of cortexin in the early rehabilitation period of ischemic stroke of moderate severity].
Nurguzhaev ES; Mitrokhin DA; Izbasarova ASh; Nurguzhaev AE; Raimkulov BN; Abdil'manova BR
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):66-9. PubMed ID: 19672239
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy and safety of choline alfoscerate in the treatment of late-onset cognitive impairment].
Gavrilova SI; Kolykhalov IV; Ponomareva EV; Fedorova YB; Selezneva ND
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5):45-53. PubMed ID: 29927403
[TBL] [Abstract][Full Text] [Related]
15. [Neuroprotective treatment with citicoline (ceraxon) in patients with ischemic stroke].
Martynov MIu; Boĭko AN; Kamchatnov PR; Kabanov AA; Iasamanova AN; Shchukin IA; Kolesnikova TI; Chubykin VI; Glukhareva AP; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 2):21-6. PubMed ID: 22677765
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases.
Cho HJ; Kim YJ
Methods Find Exp Clin Pharmacol; 2009 Apr; 31(3):171-6. PubMed ID: 19536360
[TBL] [Abstract][Full Text] [Related]
17. [Efficiency of combined therapy with myocardial cytoprotector mexicor in hypertensive patients with acute cerebrovascular disturbances].
Mikhin VP; Boldina NV; Cherniatina MA; Laskov VB; Sidorova SA
Angiol Sosud Khir; 2008; 14(4):43-8. PubMed ID: 19791551
[TBL] [Abstract][Full Text] [Related]
18. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
Diener HC; AlKhedr A; Busse O; Hacke W; Zingmark PH; Jonsson N; Basun H;
J Neurol; 2002 May; 249(5):561-8. PubMed ID: 12021946
[TBL] [Abstract][Full Text] [Related]
19. [Comparative aspects of using neuroprotectors in the management of patients with ischemic stroke].
Ershov VI
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 2):41-4. PubMed ID: 22224244
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of dapsone in patients with acute ischemic stroke: a pilot study.
Nader-Kawachi J; Góngora-Rivera F; Santos-Zambrano J; Calzada P; Ríos C
Neurol Res; 2007 Apr; 29(3):331-4. PubMed ID: 17509235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
